Virology journal · 2026
Cytomegalovirus infection drives a distinct mucosal and systemic cytokine signature in ulcerative colitis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Izadi Nasim, Shirmohammadi Masoud, Daryani Nasser Ebrahimi, Behboudi Emad, Baghi Hossein Bannazadeh, Oskouee Mahin Ahangar, Sadeghipoor Shima, Yazdani Shaghayegh, Azadi Arezou, Naghili Behrooz, Aghazadeh Mohammad, Poortahmasebi Vahdat
Аннотация
PURPOSE: Ulcerative colitis (UC) is a chronic inflammatory bowel disease in which cytomegalovirus (CMV) reactivation has been linked to severe and steroid-refractory cases. However, the effect of CMV on cytokine regulation in UC remains unclear. This study investigated colonic and systemic cytokine profiles in CMV-positive and CMV-negative UC patients.
METHODS: A total of 190 UC patients were enrolled, including 90 CMV-positive and 100 CMV-negative cases. CMV status was confirmed by molecular and histopathological tests. Colonic gene expression of cytokines (TNF-α, IL-1β, IL-6, IL-17 A, IFN-γ, TGF-β, IL-8, IL-12, and RANTES) was measured by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR), and serum concentrations were assessed using enzyme-linked immunosorbent assay (ELISA).
RESULTS: Demographic and clinical features were comparable between groups. CMV-positive patients showed higher colonic mRNA expression and serum concentrations of TNF-α, IL-1β, IL-6, and IL-17 A compared to CMV-negative patients (all p < 0.05). In contrast, IFN-γ, TGF-β, IL-8, IL-12, and RANTES did not differ significantly. Notably, CMV tissue viral load was significantly higher in patients with moderate to severe disease (Mayo score ≥ 6) and showed a positive correlation with plasma viral load (r = 0.664, p < 0.01). Multivariable logistic regression analysis adjusted for Mayo score confirmed that elevated TNF-α, IL-1β, and IL-6 remained independently associated with CMV positivity. These findings indicate a selective pro-inflammatory cytokine pattern rather than generalized immune activation.
CONCLUSION: CMV infection in UC is associated with selective upregulation of pro-inflammatory cytokines at both mucosal and systemic levels. These findings highlight CMV as a potential driver of immune amplification in UC and support cytokine profiling as a tool for risk stratification and management of affected patients.
METHODS: A total of 190 UC patients were enrolled, including 90 CMV-positive and 100 CMV-negative cases. CMV status was confirmed by molecular and histopathological tests. Colonic gene expression of cytokines (TNF-α, IL-1β, IL-6, IL-17 A, IFN-γ, TGF-β, IL-8, IL-12, and RANTES) was measured by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR), and serum concentrations were assessed using enzyme-linked immunosorbent assay (ELISA).
RESULTS: Demographic and clinical features were comparable between groups. CMV-positive patients showed higher colonic mRNA expression and serum concentrations of TNF-α, IL-1β, IL-6, and IL-17 A compared to CMV-negative patients (all p < 0.05). In contrast, IFN-γ, TGF-β, IL-8, IL-12, and RANTES did not differ significantly. Notably, CMV tissue viral load was significantly higher in patients with moderate to severe disease (Mayo score ≥ 6) and showed a positive correlation with plasma viral load (r = 0.664, p < 0.01). Multivariable logistic regression analysis adjusted for Mayo score confirmed that elevated TNF-α, IL-1β, and IL-6 remained independently associated with CMV positivity. These findings indicate a selective pro-inflammatory cytokine pattern rather than generalized immune activation.
CONCLUSION: CMV infection in UC is associated with selective upregulation of pro-inflammatory cytokines at both mucosal and systemic levels. These findings highlight CMV as a potential driver of immune amplification in UC and support cytokine profiling as a tool for risk stratification and management of affected patients.